Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
IART

IART - Integra LifeSciences Holdings Corp Stock Price, Fair Value and News

$10.88-0.25 (-2.25%)
Market Closed

50/100

IART

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

50/100

IART

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$12.26

Target 3M

$11.98

Target 6M

$12.08

IART Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IART Price Action

Last 7 days

-10.7%

Last 30 days

-13.7%

Last 90 days

-7.9%

Trailing 12 Months

-58.2%

IART RSI Chart

IART Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IART Valuation

Market Cap

847.5M

Price/Earnings (Trailing)

-1.71

Price/Sales (Trailing)

0.52

EV/EBITDA

-1.13

Price/Free Cashflow

-187.74

IART Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$12.26

Target 3M

$11.98

Target 6M

$12.08

IART Fundamentals

IART Revenue

Revenue (TTM)

1.6B

Rev. Growth (Yr)

5.57%

Rev. Growth (Qtr)

-3.26%

IART Earnings

Earnings (TTM)

-495.3M

Earnings Growth (Yr)

49.47%

Earnings Growth (Qtr)

98.88%

IART Profitability

EBT Margin

-33.19%

Return on Equity

-47.74%

Return on Assets

-13.58%

Free Cashflow Yield

-0.53%

IART Investor Care

Shares Dilution (1Y)

0.94%

Diluted EPS (TTM)

-6.46

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.6B1.6B1.6B0
20241.5B1.6B1.6B1.6B
20231.6B1.5B1.5B1.5B
20221.6B1.6B1.6B1.6B
20211.4B1.5B1.5B1.5B
20201.5B1.4B1.4B1.4B
20191.5B1.5B1.5B1.5B
20181.3B1.4B1.5B1.5B
20171.0B1.0B1.1B1.2B
2016917.0M953.6M977.6M992.1M
2015816.2M831.8M860.6M882.7M
2014822.6M814.1M798.4M796.7M
2013831.3M826.7M829.9M836.2M
2012795.2M812.1M820.0M830.9M
2011740.4M755.1M770.7M780.1M
2010000732.1M
Get all data in R, Python etc through our Historical Stock Data APIs

About Integra LifeSciences Holdings Corp

IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
 CEO
 WEBSITEintegralife.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES3722

Integra LifeSciences Holdings Corp Frequently Asked Questions

IART is the stock ticker symbol of Integra LifeSciences Holdings Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Integra LifeSciences Holdings Corp is 847.47 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check IART's fair value in chart for subscribers.

The fair value guage provides a quick view whether IART is over valued or under valued. Whether Integra LifeSciences Holdings Corp is cheap or expensive depends on the assumptions which impact Integra LifeSciences Holdings Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IART.

As of Wed Jan 28 2026, IART's PE ratio (Price to Earnings) is -1.71 and Price to Sales (PS) ratio is 0.52. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IART PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Integra LifeSciences Holdings Corp has provided -0.099 (multiply by 100 for percentage) rate of return.